SMAD3 and renal fibrosis: Dysregulation of Smad7 promotes renal fibrosis (Chung et al., 2013) and conversely Smad7 treatment substantially attenuating progressive kidney diseases via inactivating TGF-β/Smad3 signaling (Zhou et al., 2016).